Skip to search formSkip to main contentSkip to account menu

Hyperphosphatemia (disorder)

Known as: Hyperphosphatemias, Hyperphosphatemia, Hyperphosphatemia [Disease/Finding] 
A condition of abnormally high level of PHOSPHATES in the blood, usually significantly above the normal range of 0.84-1.58 mmol per liter of serum.
National Institutes of Health

Related topics

Related topics

20 relations
Disorder of electrolytesHYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROMEHyperphosphaturiaIn Blood

Narrower (1)

Hyperostosis-hyperphosphatemia syndrome

Broader (1)

Phosphorus Metabolism Disorders

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial.
BACKGROUND Recently, nicotinamide has been suggested as an effective drug for hyperphosphatemia in hemodialysis patients. The… 
Highly Cited
2007
Highly Cited
2007
Are PTH serum levels predictive of coronary calcifications in haemodialysis patients?
BACKGROUND Cardiac calcifications are a frequent occurrence in uraemic subjects and are probably connected to the increased… 
Review
2005
Review
2005
Pathogenesis of vascular calcification in dialysis patients
Soft-tissue and vascular calcification are highly prevalent in end-stage renal disease (ESRD). Vascular calcifications manifest… 
Highly Cited
2005
Highly Cited
2005
Surgical Indications and Procedures of Parathyroidectomy in Patients with Chronic Kidney Disease
Abstract:  The Kidney Foundation of the USA proposed clinical practice guidelines for bone metabolism and disease in chronic… 
Highly Cited
1994
Highly Cited
1994
Acid-base and electrolyte abnormalities in alcoholic patients.
This study was undertaken to analyze the acid-base and electrolyte abnormalities and the pathogenetic mechanisms involved in… 
Highly Cited
1991
Highly Cited
1991
The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients.
Secondary hyperparathyroidism is common in dialysis patients. Intravenous calcitriol has proven to be an effective therapy for… 
Review
1989
Review
1989
Tumor lysis syndrome in nonhematopoietic neoplasms
A 57‐year‐old woman developed severe tumor lysis syndrome characterized by acute hyperuricemic nephropathy, hyperphosphatemia… 
Highly Cited
1981
Highly Cited
1981
Metabolic abnormalities in patients supported with enteral tube feeding.
One hundred patients supported with enteral tube feeding were evaluated for biochemical abnormalities. The following metabolic… 
Highly Cited
1976
Highly Cited
1976
1,25-Dihydroxycholecalciferol deficiency: the probable cause of hypocalcemia and metabolic bone disease in pseudohypoparathyroidism.
Pseudohypoparathyroidism (PsH) is a genetic disease characterized by hypocalcemia, hyperphosphatemia, and metabolic… 
Highly Cited
1967
Highly Cited
1967
Bone and mineral metabolism in hyperthyroidism: an experimental study.
The effect of thyroxine-induced hyperthyroidism on bone and on mineral metabolism was studied in adult, parathyroid-intact and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)